Multimodal spatial profiling of fallopian tube precursors (Kader et al., 2025), published in Cancer Discovery, asks what changes in the fallopian tube as precancerous lesions progress to high-grade serous ovarian cancer (HGSOC), which arises there. The authors combined highly multiplexed imaging with spatial transcriptomics across stages of the disease: p53 signatures, serous tubal intraepithelial carcinomas (STICs) and invasive cancer.
Explore the data: Open the dataset in the Discovery Lab TRE to run reproducible analyses where the data resides.
Dataset page · Open in the Discovery Lab TRE
Key Findings
- Precursors already show cancer-like changes. The precursor epithelium carries chromosomal instability and persistent interferon signaling.
- MHC class I is raised early. Fallopian tube precursors express more MHC class I, including HLA-E, and more interferon-stimulated genes, changes usually linked to later-stage tumors.
- Immunity shifts from surveillance to suppression. The surrounding immune environment moves from immune surveillance in early STICs to immune suppression in advanced STICs and cancer.
This Slide
The view below is one tissue section imaged by cyclic immunofluorescence (CyCIF): 53 channels over 13 cycles, of which 11 are kept here. It comes from a BRCA2 mutation carrier, 64 at diagnosis, whose risk-reducing surgery found an incidental STIC in the right fallopian tube. Each figure can be panned and zoomed.
Paper: Kader T, Lin J-R, Hug CB, et al. Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma. Cancer Discovery 15, 1180–1202 (2025). doi:10.1158/2159-8290.CD-24-1366